Snooze and you’ll miss it. “Companies and observers generally expect at least one COVID-19 candidate vaccine soon will receive a regulatory thumbs up,” explains the newspaper.
But you can grab a cup of coffee first—because distribution could take time.
One complication is that vaccines differ in dosage and storage requirements: “[T]he Pfizer-BioNTech vaccine shots are given 21 days apart, while Moderna’s second shot is delivered at 28 days. Moderna’s vaccine must be kept frozen. Pfizer’s has to be kept even colder—at minus-78 degrees Fahrenheit, the temperature of dry ice—meaning it needs different shipping and storing protocols,” explains USA TODAY.
But we need multiple COVID-19 vaccines to cross the finish line—to ensure everyone regardless of age, ethnicity, or health status has a safe, effective vaccine, BIO’s Dr. Michelle McMurry-Heath explained.
Dr. Michelle’s Diagnosis: The more solutions we have, the better prepared we will be to end this global pandemic. – BIO President and CEO Dr. Michelle McMurry-Heath
More Health Care News:
NPR: FDA panel to lay regulatory groundwork for COVID-19 vaccine
“A milestone in the development of COVID-19 vaccines will take place Thursday when the Food and Drug Administration will ask a panel of experts for advice on how to evaluate the vaccines.”
The Wall Street Journal (Opinion): I should have worn a mask
“It’s not a partisan or cultural symbol, not a sign of weakness or virtue,” says former New Jersey Gov. Chris Christie, who spent a week in the ICU with COVID-19.